<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shaw TI</submitter><funding>NCI NIH HHS</funding><funding>NIH</funding><funding>NIGMS NIH HHS</funding><pagination>5154</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7933146</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>USP7, which encodes a deubiquitylating enzyme, is among the most frequently mutated genes in pediatric T-ALL, with somatic heterozygous loss-of-function mutations (haploinsufficiency) predominantly affecting the subgroup that has aberrant TAL1 oncogene activation. Network analysis of > 200 T-ALL transcriptomes linked USP7 haploinsufficiency with decreased activities of E-proteins. E-proteins are also negatively regulated by TAL1, leading to concerted down-regulation of E-protein target genes involved in T-cell development. In T-ALL cell lines, we showed the physical interaction of USP7 with E-proteins and TAL1 by mass spectrometry and ChIP-seq. Haploinsufficient but not complete CRISPR knock-out of USP7 showed accelerated cell growth and validated transcriptional down-regulation of E-prote</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL).</pubmed_title><pmcid>PMC7933146</pmcid><funding_grant_id>R01 GM134382</funding_grant_id><funding_grant_id>R01 CA216391</funding_grant_id><funding_grant_id>1R01CA216391-01A1</funding_grant_id><funding_grant_id>R35 CA210064</funding_grant_id><pubmed_authors>Shaw TI</pubmed_authors><pubmed_authors>Cheng C</pubmed_authors><pubmed_authors>Tian L</pubmed_authors><pubmed_authors>Look AT</pubmed_authors><pubmed_authors>Qian C</pubmed_authors><pubmed_authors>Kavdia K</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Pagala VR</pubmed_authors><pubmed_authors>Easton J</pubmed_authors><pubmed_authors>Gu W</pubmed_authors><pubmed_authors>Ma X</pubmed_authors><pubmed_authors>Dong L</pubmed_authors><pubmed_authors>Choi J</pubmed_authors><pubmed_authors>Porter SN</pubmed_authors><pubmed_authors>Yu J</pubmed_authors><pubmed_authors>Ju B</pubmed_authors><pubmed_authors>Pei D</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Pruett-Miller SM</pubmed_authors><pubmed_authors>High A</pubmed_authors><pubmed_authors>Janke LJ</pubmed_authors><pubmed_authors>Downing JR</pubmed_authors><pubmed_authors>Shaner B</pubmed_authors><pubmed_authors>Peng J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL).</name><description>USP7, which encodes a deubiquitylating enzyme, is among the most frequently mutated genes in pediatric T-ALL, with somatic heterozygous loss-of-function mutations (haploinsufficiency) predominantly affecting the subgroup that has aberrant TAL1 oncogene activation. Network analysis of > 200 T-ALL transcriptomes linked USP7 haploinsufficiency with decreased activities of E-proteins. E-proteins are also negatively regulated by TAL1, leading to concerted down-regulation of E-protein target genes involved in T-cell development. In T-ALL cell lines, we showed the physical interaction of USP7 with E-proteins and TAL1 by mass spectrometry and ChIP-seq. Haploinsufficient but not complete CRISPR knock-out of USP7 showed accelerated cell growth and validated transcriptional down-regulation of E-prote</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2026-05-03T08:53:16.089Z</modification><creation>2021-03-09T08:17:39Z</creation></dates><accession>S-EPMC7933146</accession><cross_references><pubmed>33664368</pubmed><doi>10.1038/s41598-021-84647-2</doi></cross_references></HashMap>